Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Sciences

Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for the Biodistribution of [18F] 2-Deoxy-2-Fluoro-D-Glucose

Brian M. Gallagher, Joanna S. Fowler, Neal I. Gutterson, Robert R. MacGregor, Chung-Nan Wan and Alfred P. Wolf
Journal of Nuclear Medicine October 1978, 19 (10) 1154-1161;
Brian M. Gallagher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna S. Fowler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neal I. Gutterson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert R. MacGregor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chung-Nan Wan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred P. Wolf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 19, Issue 10
October 1, 1978
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for the Biodistribution of [18F] 2-Deoxy-2-Fluoro-D-Glucose
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for the Biodistribution of [18F] 2-Deoxy-2-Fluoro-D-Glucose
Brian M. Gallagher, Joanna S. Fowler, Neal I. Gutterson, Robert R. MacGregor, Chung-Nan Wan, Alfred P. Wolf
Journal of Nuclear Medicine Oct 1978, 19 (10) 1154-1161;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for the Biodistribution of [18F] 2-Deoxy-2-Fluoro-D-Glucose
Brian M. Gallagher, Joanna S. Fowler, Neal I. Gutterson, Robert R. MacGregor, Chung-Nan Wan, Alfred P. Wolf
Journal of Nuclear Medicine Oct 1978, 19 (10) 1154-1161;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?
  • Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting
  • Organ-Specific Fuel Rewiring in Acute and Chronic Hypoxia Redistributes Glucose and Fatty Acid Metabolism
  • Gallaghers Principle of Metabolic Trapping (perspective on "Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for Biodistribution of [18F]2-Deoxy-2-Fluoro-D-Glucose" J Nucl Med. 1978;19:1154-1161)
  • Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool
  • PET/CT in nononcological lung diseases: current applications and future perspectives
  • Elevated 18F-FDG Levels in Blood and Organs After Angiotensin II Receptor Blocker Administration: Experiment in Mice Administered Telmisartan
  • Targeted Cancer Therapy with a 2-Deoxyglucose-Based Adriamycin Complex
  • Is Liver SUV Stable over Time in 18F-FDG PET Imaging?
  • Could Different Hydration Protocols Affect the Quality of 18F-FDG PET/CT Images?
  • Role of Functional Imaging in the Management of Lymphoma
  • Impact of 18F-FDG PET/CT with Retrograde Filling of the Urinary Bladder in Patients with Suspected Pelvic Malignancies
  • Design of Targeted Cardiovascular Molecular Imaging Probes
  • Modern Staging and Utility of PET Imaging in Esophageal Cancer Management
  • Targeting of VX2 Rabbit Liver Tumor by Selective Delivery of 3-Bromopyruvate: A Biodistribution and Survival Study
  • Histone Deacetylase Inhibition and Blockade of the Glycolytic Pathway Synergistically Induce Glioblastoma Cell Death
  • Dynamic Small-Animal PET Imaging of Tumor Proliferation with 3'-Deoxy-3'-18F-Fluorothymidine in a Genetically Engineered Mouse Model of High-Grade Gliomas
  • 18F-FDG PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder Cancer
  • Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis
  • Positherapy: Targeted Nuclear Therapy of Breast Cancer with 18F-2-Deoxy-2-Fluoro-D-Glucose
  • Analysis of the Regional Uptake of Radiolabeled Deoxyglucose Analogs in Human Tumor Xenografts
  • Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma
  • Enhancing Targeted Radiotherapy by Copper(II)diacetyl- bis(N4-methylthiosemicarbazone) Using 2-Deoxy-D-Glucose
  • 3'-Deoxy-3'-[18F]Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography
  • Evaluation of 18F-FDG PET in Patients with Advanced, Metastatic, or Recurrent Gastric Cancer
  • 18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax
  • Metabolic Fate of 18F-FDG in Mice Bearing Either SCCVII Squamous Cell Carcinoma or C3H Mammary Carcinoma
  • FDG Uptake and Glucose Transporter Subtype Expressions in Experimental Tumor and Inflammation Models
  • Dual Time Point 18F-FDG PET Imaging for Differentiating Malignant from Inflammatory Processes
  • Cellular Release of [18F]2-Fluoro-2-deoxyglucose as a Function of the Glucose-6-phosphatase Enzyme System
  • Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
  • Whole-Body Positron Emission Tomography Using 18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin's Disease and Non-Hodgkin's Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging
  • Current role of positron emission tomography in thoracic oncology
  • Prediction of Improvement of Contractile Function in Patients With Ischemic Ventricular Dysfunction After Revascularization by Fluorine-18 Fluorodeoxyglucose Single-Photon Emission Computed Tomography
  • Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects
  • Positron emission tomography: human brain function and biochemistry
  • Metabolic mapping of the brain's response to visual stimulation: studies in humans
  • Cellular Release of [18F]2-Fluoro-2-deoxyglucose as a Function of the Glucose-6-phosphatase Enzyme System
  • Google Scholar

More in this TOC Section

Basic Sciences

  • Three-Dimensional Display of Gated Cardiac Blood-Pool Studies
  • Captopril Renal Scintigraphy in a Patient with Bilateral Renal Artery Stenosis
  • Nuclear Medicine Imaging of Systemic Mastocytosis
Show more Basic Sciences

Radiochemistry and Radiopharmaceuticals

  • The Synthesis of 2-[F-18]Fluoro-2-Deoxy-D-Glucose Using Glycals: A Reexamination
  • 15(p-[123I]Iodophenyl)Penadecanoic Acid as Tracer of Lipid Metabolism: Comparison with [1-14C]Palmitic Acid in Murine Tissues
  • Development of a Model System to Evaluate Methods for Radiolabeling Monoclonal Antibodies
Show more Radiochemistry and Radiopharmaceuticals

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire